Möhwald, Ken http://orcid.org/0000-0003-3112-2134
Wuehr, Max
Schenkel, Fabian
Feil, Katharina
Strupp, Michael
Schniepp, Roman
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01EO1401)
Article History
Received: 15 March 2020
Revised: 16 August 2020
Accepted: 18 August 2020
First Online: 11 September 2020
Compliance with ethical standards
:
: K. Möhwald, M. Wuehr, F. Schenkel, K. Feil and R. Schniepp report no disclosures or conflicts of interest. M. Strupp is Joint Chief Editor of the Journal of Neurology, Editor in Chief of Frontiers of Neuro-otology and Section Editor of F1000. He has received speaker’s honoraria from Abbott, Actelion, Auris Medical, Bayer, Biogen, Eisai, Grünenthal, GSK, Henning Pharma, Interacoustics, Merck, MSD, Otometrics, Pierre-Fabre, TEVA, and UCB. He is a shareholder of IntraBio. He acts as a consultant for Abbott, Actelion, AurisMedical, Heel, IntraBio and Sensorion.
: The study procedures have been approved by the Ethics Committee of the University of Munich. All procedures were in accordance with the Declaration of Helsinki and all patients gave their written informed consent.